For over 30 years, IDT has provided a full scale service from initial API drug development to Clinical Trials. Globally, we’ve worked with 9 of the Top 10 Pharmaceutical companies, bringing a superior level of innovation and expertise to every project, whether cGMP high-potency API manufacture, finished dosage form development & scale-up, analytical testing, clinical packaging, or clinical trials and pharmacy services. Located in Melbourne and Adelaide, Australia our facilities are fully cGMP (GLP, GCP) and are audited by the US FDA and Australia’s TGA.
Successful companies rely on new products to keep them ahead of the competition, but developing and bringing them to market on time and on budget needs knowledge, competence and a proven track record. What sets IDT apart is our ability to combine a cross-functional understanding of the challenges of drug development with the application of our world-class R&D, manufacturing and clinical trial facilities and processes to accomplish your project on time, within budget and to the highest global quality standards. Whether it is API synthesis, finished dose product manufacturing, analytical testing, clinical packaging or a first in man clinical study, IDT can tailor a flexible and responsive approach to suit your individual project’s needs.

Download our brochure

View a short video showcasing the Melbourne Manufacturing Campus

Having the right resources, partners and competencies at each point in the development process are critical success factors.  Knowing where to access both the expertise and experience cost-effectively is a major project management decision. IDT has both the expertise and resources to assist managing your drug development and commercial production requirements with a collaborative approach that is innovative, reliable and commercially successful.